Report Overview:
Diabetes lancets are small, pricking needles designed for single use to obtain drops of blood for glucose monitoring. These devices are commonly used by individuals with diabetes to test blood sugar levels, aiding in the management of their condition. Lancets are essential components in self-monitoring of blood glucose (SMBG) and are designed to minimize pain and discomfort. They are widely used in home settings, hospitals, and retail pharmacies, ensuring effective diabetes management.
Market Value:
The global Diabetes Lancets for Home market was valued at USD 1057 million in 2024 and is projected to reach USD 1668.08 million by 2032, exhibiting a CAGR of 5.20% during the forecast period. The rising prevalence of diabetes, increasing awareness about self-monitoring, and technological advancements in lancet design contribute to this growth.
CAGR of 5.20% (2025 – 2032)
By Types:
• Safety Lancets with Needle
• Safety Lancets with Blade
By Applications: Hospital
Retail Pharmacy
Key players include:
• Roche
• BD (Becton, Dickinson, and Company)
• Ascensia
• Lifescan
• B. Braun
• Terumo
• Nipro
• Including or Excluding key companies relevant to your analysis.
